Ioos C, Barois A, Richard P, Eymard B, Hantaï D, Estournet-Mathiaud B
Service de Neuropédiatrie, Hôpital Raymond Poincaré, Garches, France.
Neuropediatrics. 2004 Aug;35(4):246-9. doi: 10.1055/s-2004-820993.
We report the cases of 3 children with postsynaptic congenital myasthenic syndrome with acetylcholine receptor deficiency due to rapsyn deficiency. Symptoms began at the neonatal period with hypotonia, arthrogryposis, bulbar symptoms, and respiratory distress. Two of the 3 children needed tracheostomy and gastrostomy. Electromyograms showed a decremental response to repetitive stimulation. Muscle biopsies were normal or showed type I fiber preponderance. Genetic studies identified mutations in the rapsyn gene (RAPSN). The 3 patients were heterozygous for N88 K and a second mutation (either Y86X, 1083_1084 dupCT or IVS4-2 A > G). The patients responded favorably to anticholinesterase treatment, with a clear improvement of clinical symptoms, especially the bulbar symptoms of apneas and swallowing disturbances. This paper underlines the importance of anticholinesterase medication in patients with congenital myasthenic syndrome due to rapsyn deficiency.
我们报告了3例因rapsyn缺乏导致乙酰胆碱受体缺乏的突触后先天性肌无力综合征患儿的病例。症状始于新生儿期,表现为肌张力减退、关节挛缩、延髓症状和呼吸窘迫。3名儿童中有2名需要气管切开术和胃造口术。肌电图显示对重复刺激的反应递减。肌肉活检正常或显示I型纤维优势。基因研究确定了rapsyn基因(RAPSN)中的突变。这3例患者为N88K杂合子及另一个突变(Y86X、1083_1084 dupCT或IVS4-2 A>G)。患者对抗胆碱酯酶治疗反应良好,临床症状明显改善,尤其是呼吸暂停和吞咽障碍等延髓症状。本文强调了抗胆碱酯酶药物在rapsyn缺乏所致先天性肌无力综合征患者中的重要性。